Rajulkumar Shamji Makadia

Rajulkumar Shamji Makadia

Active Director Managing Director DIN 06399498
DIN 06399498 First appointment Jan 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Jan 2013
Shareholding value •••• Premium profile

About Rajulkumar Shamji Makadia

Data last updated:

Rajulkumar Shamji Makadia is a Managing Director at Adroit Pharmachem Private Limited (since 2013), Managing Director at Adroit Naturals Private Limited (since 2022) and Director at Adroit Pharma Research Private Limited (since 2016). The companies operate in Pharma, Agriculture and Internet. The 3 current companies with reported revenue have a combined latest revenue of ₹138 Cr; the largest is Adroit Pharmachem Private Limited at ₹83.57 Cr (FY 2025). Earlier, Rajulkumar Shamji Makadia was a Director at Ultra Tech Transmissions Private Limited (2017–2018).

DIN 06399498
Primary Designation Managing Director
Industry Pharma
First Appointment 11 Jan 2013
Oldest Company Age 26 yrs
Largest company Adroit Pharmachem Private Limited · ₹83.57 Cr (FY 2025)
Combined revenue ₹138 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adroit Pharmachem Private Limited U24100GJ2013PTC073351
Managing Director11 Jan 20132013₹83.57 Cr (FY 2025)Active
Adroit Naturals Private Limited U24299GJ2022PTC133110
Managing Director21 Jun 20222022₹51.13 Cr (FY 2025)Active
Director03 Feb 20161999₹3.34 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jun 20172011₹8.80 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Adroit Naturals Private Limited
Adroit Pharmachem Private Limited
Adroit Pharma Research Private Limited
Ultra Tech Transmissions Private Limited
Premium access

Shareholding and investment profile for Rajulkumar Shamji Makadia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajulkumar Shamji Makadia

Rajulkumar Shamji Makadia currently holds 3 directorships: Adroit Pharmachem Private Limited (Managing Director, since 11 Jan 2013, revenue ₹83.57 Cr (FY 2025)); Adroit Naturals Private Limited (Managing Director, since 21 Jun 2022, revenue ₹51.13 Cr (FY 2025)); Adroit Pharma Research Private Limited (Director, since 03 Feb 2016, revenue ₹3.34 Cr (FY 2025)).

Rajulkumar Shamji Makadia was first appointed on 11 Jan 2013 as Managing Director at Adroit Pharmachem Private Limited. The most recent appointment on record is 21 Jun 2022 at Adroit Naturals Private Limited.

The 3 current companies of Rajulkumar Shamji Makadia that report revenue have a combined latest revenue of ₹138 Cr: Adroit Pharmachem Private Limited ₹83.57 Cr (FY 2025); Adroit Naturals Private Limited ₹51.13 Cr (FY 2025); Adroit Pharma Research Private Limited ₹3.34 Cr (FY 2025).

Rajulkumar Shamji Makadia held 1 earlier board appointment: Ultra Tech Transmissions Private Limited (Director, 19 Jun 2017 to 16 Jun 2018).

The current boards of Rajulkumar Shamji Makadia's companies include Alpeshkumar Ratilal Sinojia (Adroit Pharmachem Private Limited), Nileshkumar Shamjibhai Makadia (Adroit Pharmachem Private Limited), Chetankumar Ratilal Sinojia (Adroit Naturals Private Limited), Dev Rajulkumar Makadia (Adroit Naturals Private Limited), Jeetkumar Nileshkumar Makadia (Adroit Naturals Private Limited), Priti Alpeshkumar Sinojia (Adroit Pharma Research Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available